Hepatitis C Virus Infection Clinical Trials

104 clinical trials for Hepatitis C Virus Infection across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Hepatitis C Tracker Study — RECRUITING · NA
• Early Detection of HCV in Injection Drug Users — RECRUITING
• Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Cancer Development — RECRUITING
• A study with sofosbuvir and ribavirin in patients co-infected with HIV and HCV — COMPLETED · PHASE3
• A study comparing 3 different treatments and treatment durations for hepatitis C — COMPLETED · PHASE3
• Non-Invasive Risk Stratification for Hepatocellular Carcinoma in HCV-Related Compensated Advanced Chronic Liver Disease Following Sustained Virological Response: Validation of the aMAP Score — COMPLETED
• C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV — ACTIVE_NOT_RECRUITING · PHASE3
• Digital Community to Improve Health in Rural Areas — COMPLETED · NA
• Relinking Diagnosed But Untreated HCV Patients Back Into Care. — COMPLETED
• Access to Hepatitis C Treatment in Cameroon: Comparison of a Simplified Test and Treat Strategy to a Standard Strategy — NOT_YET_RECRUITING · PHASE4
• Screening, Treatment, and Eradication of Hep C — NOT_YET_RECRUITING
• Interventions to Curb Hepatitis C Reinfections Among Men Who Have Sex With Men — ACTIVE_NOT_RECRUITING · NA
• Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia — OTHER
• Adult Screening for Hepatitis c and Linkage to Treatment in Hospitals in Colombia — OTHER
• A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection — TERMINATED
• Simplification and Test and Treat Strategies Towards Hepatitis C Eliminationplatform" in China(STAT) — OTHER
• Telemedicine for Linkage to Care People Who Injected Drugs With Hepatitis C — OTHER · NA
• Implementing HCV Treatment for High-risk Populations in Austin, Texas — OTHER · NA
• A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials — TERMINATED
• CARES-HCV: Promoting Screening Uptake Among Diverse Baby Boomers — COMPLETED
• Pharmacokinetics of Sofosbuvir/Daclatasvir in HCV-infected Lactating Women — OTHER
• Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study — COMPLETED
• Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects — WITHDRAWN · PHASE1
• Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study — COMPLETED · PHASE3
• Pharmacist-led Hepatitis C Management — OTHER · PHASE4
• Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination for 12 Weeks in Adults With Chronic HCV Infection and Compensated Cirrhosis — COMPLETED · PHASE3
• Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) for Patients With Hepatitis C Virus Infection — OTHER
• Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection — COMPLETED · PHASE3
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis — COMPLETED · PHASE3
• A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2) — COMPLETED · PHASE3
• A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 Coinfection — COMPLETED · PHASE2
• Integrating Hepatitis C Screening With Dried Blood Spot Testing Into Colorectal Cancer Screening — COMPLETED · NA
• HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy — OTHER
• HCV Reinfection in HD Patients Achieving SVR — OTHER
• Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection — TERMINATED · PHASE2
• Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection — COMPLETED · PHASE2
• Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection — COMPLETED · PHASE1
• Evaluation Study of HCV RDTs in Fresh Samples — COMPLETED
• DBS Evaluation of Fujirebio INNOTEST® HCV Ab IV — COMPLETED · NA
• Ombitasvir /Paritaprevir/Ritonavir Plus Ribavirin on HCV GT4 — COMPLETED · PHASE1
• Sofosbuvir/Pegylated-interferon Plus Ribavirin With HCV Genotype 4 — COMPLETED · PHASE1
• Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection — COMPLETED · PHASE2
• Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection — COMPLETED · PHASE2
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Adults With Chronic HCV and HBV Coinfection — COMPLETED · PHASE3
• Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection — COMPLETED · PHASE2
• Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy — COMPLETED · PHASE2
• Evaluate the Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 Weeks in Participants With Chronic HCV Infection and Child-Pugh-Turcotte Class C Cirrhosis — COMPLETED · PHASE2
• Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination +/- Ribavirin in Adolescents and Children With Chronic HCV-Infection — COMPLETED · PHASE2
• Ledipasvir/Sofosbuvir in Adults With Chronic Hepatitis C Virus (HCV) Infection Who Are on Dialysis for End Stage Renal Disease — COMPLETED · PHASE2
• Prevalence of HCV in HIV-negative MSM — OTHER · NA

Refine this search